20 articles
Axalta Coating Systems voluntarily expanded its merger proxy statement with additional financial advisor analyses and disclosed two shareholder lawsuits seeking to block its pending combination with AkzoNobel.
Hayward Holdings disclosed the final approval of a $19.85 million securities class action settlement in its latest quarterly report, resolving claims that the company and certain executives misled investors about inventory and growth prospects between October 2021 and July 2022.
uniQure N.V. reported in its latest quarterly filing that it has reached a preliminary settlement to resolve a consolidated securities class action lawsuit, while also continuing to defend against two shareholder derivative actions.
Katapult Holdings disclosed two stockholder lawsuits and several demand letters challenging its merger proxy disclosures, and it has voluntarily issued supplemental information ahead of the August 6 special meeting to approve its business combination with Aaron's and CCF Holdings.
VSee Health entered a settlement agreement with ADI Funding and M2B Funding to resolve a default notice on a $271,739 secured note, agreeing to repay the debt, make a $50,000 cash payment, and issue additional convertible promissory notes and restricted shares.
Fly-E Group's annual report details a settled trademark infringement lawsuit with UL LLC and ongoing securities litigation stemming from a sharp revenue decline and stock drop in 2025.
EyePoint will pay $4.7 million to resolve federal and state allegations that it paid kickbacks to ambulatory surgery centers to induce purchases of its post-cataract surgery drug DEXYCU, and has entered a five-year corporate integrity agreement with the HHS Office of Inspector General.
Organon voluntarily added disclosures to its definitive proxy statement after a stockholder filed a lawsuit seeking to halt the July 23 special meeting vote on the company's acquisition by Sun Pharma.
River Financial Corporation reported that two additional class action lawsuits have been filed against the company in connection with the June ransomware attack, bringing the total to four.
Arbutus Biopharma received its $178 million share of Moderna’s $950 million patent settlement payment and disclosed performance bonuses for its CEO and CFO tied to litigation proceeds.
Regen BioPharma reached a court-approved settlement to resolve a $398,740 claim by issuing shares of its stock, and it replaced its independent auditor after that firm’s attest business was acquired.
River Financial disclosed that a threat actor removed data from its network during the June ransomware incident, and two class action lawsuits have been filed against the company.
Sentient Brands Holdings entered into confidential pre-filing settlement agreements with two former managers, who agreed to surrender 455,496 restricted shares for cancellation and provide cooperation in planned litigation over allegedly improper historical share issuances.
ProPhase Labs filed a second amendment to its first-quarter report, restating financials to correct errors in revenue and costs.
NSA voluntarily supplemented its merger proxy statement with new details on its evaluation process, Morgan Stanley's analysis, and financial projections for a related joint venture.
ProPhase Labs filed an amended first-quarter report because its independent auditor had not finished reviewing the financial statements before the original June 30 deadline.
Whitestone REIT voluntarily added disclosures to its definitive proxy statement after shareholders filed three lawsuits and sent twelve demand letters challenging the adequacy of the original disclosures related to its acquisition by Ares.
ProPhase Labs reported a $5.4 million net loss for the first quarter of 2026, pushing its total stockholders' equity to a deficit of $614,000. The company's cash reserves dwindled to just $31,000 while its short-term debt and accounts payable continued to climb.
Eco Science Solutions posted its first $253 in revenue from its Herbo Pay platform but remains a going concern with a defaulted promissory note tied to a settled shareholder derivative lawsuit.
Select Medical added new financial details to its merger proxy statement after three shareholder lawsuits and eleven demand letters alleged the original disclosures omitted material information about the $16.50-per-share buyout.
© 2026 Record Alpha. All rights reserved.